Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Leases (2022 - 2026)

Core Laboratories filings provide 5 years of Leases readings, the most recent being $54.7 million for Q1 2026.

  • On a quarterly basis, Leases fell 4.84% to $54.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $54.7 million, a 4.84% decrease, with the full-year FY2025 number at $54.3 million, down 3.79% from a year prior.
  • Leases hit $54.7 million in Q1 2026 for Core Laboratories, up from $54.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $57.5 million in Q1 2025 to a low of $52.4 million in Q4 2022.
  • Median Leases over the past 5 years was $54.7 million (2026), compared with a mean of $54.8 million.
  • Biggest five-year swings in Leases: increased 7.19% in 2025 and later dropped 4.84% in 2026.
  • Core Laboratories' Leases stood at $52.4 million in 2022, then grew by 2.79% to $53.8 million in 2023, then rose by 4.91% to $56.5 million in 2024, then fell by 3.79% to $54.3 million in 2025, then grew by 0.67% to $54.7 million in 2026.
  • The last three reported values for Leases were $54.7 million (Q1 2026), $54.3 million (Q4 2025), and $54.0 million (Q3 2025) per Business Quant data.